Ellagic Acid Prevents α-Synuclein Spread and Mitigates Toxicity by Enhancing Autophagic Flux in an Animal Model of Parkinson’s Disease
Open Access
Abstract
Parkinson’s disease (PD) is the second most common neurological disorder, pathologically characterized by loss of dopaminergic neurons in the substantia nigra pars compacta (SNc) as well as the formation of Lewy bodies composed mainly of α-synuclein (α-syn) aggregates. It has been documented that abnormal aggregation of α-syn is one of the major causes of developing PD. In the current study, administration of ellagic acid (EA), a polyphenolic compound (10 mg/kg bodyweight), significantly decreased α-syn spreading and preserved dopaminergic neurons in a male C57BL/6 mouse model of PD. Moreover, EA altered the autophagic flux, suggesting the involvement of a restorative mechanism meditated by EA treatment. Our data support that EA could play a major role in the clearing of toxic α-syn from spreading, in addition to the canonical antioxidative role, and thus preventing dopaminergic neuronal death.Keywords
Funding Information
- UPAR (12M104, 31R234)
- Zayed Center for Health Sciences, United Arab Emirates University, Al Ain (12M104, 31R234)
This publication has 69 references indexed in Scilit:
- The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's diseaseFrontiers in Computational Neuroscience, 2013
- Preventive and Prophylactic Mechanisms of Action of Pomegranate Bioactive ConstituentsEvidence-Based Complementary and Alternative Medicine, 2013
- Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in ratsPharmacological Research, 2012
- Phosphorylated α-Synuclein at Ser-129 Is Targeted to the Proteasome Pathway in a Ubiquitin-independent MannerJournal of Biological Chemistry, 2010
- Pomegranate juice: a heart-healthy fruit juiceNutrition Reviews, 2009
- The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregatesNeuropathology, 2007
- Staging of brain pathology related to sporadic Parkinson’s diseaseNeurobiology of Aging, 2003
- Extraction, stability, and quantitation of ellagic acid in various fruits and nutsJournal of Food Composition and Analysis, 1989
- Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+FEBS Letters, 1985
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983